SB
ALMS

Samsara BioCapital’s Alumis Inc ALMS Stock Holding History

Samsara BioCapital’s Portfolio ALMS Stock Details ALMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$140M Buy
6,345,219
+588,235
+10% +$14.7M 13.58% 3
2025
Q4 		$56.2M Buy
5,756,984
+955,614
+20% +$6.67M 5.8% 5
2025
Q3 		$19.2M Hold
4,801,370
– – 2.5% 6
2025
Q2 		$14.4M Buy
4,801,370
+1,534,872
+47% +$7.25M 2.95% 8
2025
Q1 		$20.1M Hold
3,266,498
– – 3.58% 5
2024
Q4 		$25.7M Hold
3,266,498
– – 3.52% 8
2024
Q3 		$34.9M Buy
+3,266,498
New +$39.6M 6.71% 5

Other funds holding ALMS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return

Samsara BioCapital's ALMS Position: Q1 2026 in Review

Samsara BioCapital increased its Alumis Inc (ALMS) stake by 10% in Q1 2026, buying an estimated $14.7M and bringing the position to 6,345,219 shares worth $140M. The position accounts for 13.58% of the portfolio, ranked #3.

Samsara BioCapital first reported a position in ALMS in Q3 2024 and has held it in 7 quarters since. 195 funds tracked by Wall St. Rank hold ALMS as of Q1 2026.

  • Samsara BioCapital held 6,345,219 shares of Alumis Inc worth $140M as of Q1 2026.
  • Samsara BioCapital bought 588,235 Alumis Inc shares in Q1 2026, an estimated $14.7M.
  • Alumis Inc made up 13.58% of Samsara BioCapital's portfolio in Q1 2026, its #3 holding.
  • Samsara BioCapital first reported a position in Alumis Inc in Q3 2024 and has held it in 7 quarters since.
  • 195 funds tracked by Wall St. Rank held Alumis Inc as of Q1 2026.

Based on Samsara BioCapital's 13F filing for Q1 2026, filed 15 May 2026.